source
- FDA greenlights Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has approved a new therapy from Vera Therapeutics aimed at treating IgA nephropathy, a chronic autoimmune kidney disorder. The drug, called Trutakna, is intended for patients with this con…
- FDA grants accelerated approval to Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has granted accelerated approval to Trutakna (formerly known as atacicept) from Vera Therapeutics for adult patients with IgA nephropathy, a chronic kidney disease that can progress to rena…